Skip to main content
MedoxyMedoxyHealthcare Pvt Ltd
Product division

Gastroenterology

Digestive-health catalogue entries organized by category, dosage form, pack information, and trade inquiry route.

Categories are provided for B2B catalogue navigation and do not establish an approved indication, product classification, clinical suitability, or destination-market availability.

14 catalogue entries7 listed categories5 listed dosage formsProduct-specific inquiries
  • Category-based catalogue
  • Multiple listed dosage forms
  • Product-specific inquiry routing

14

Catalogue entries

7

Listed categories

5

Listed dosage forms

4

Featured entries

Products

Gastroenterology product catalogue

Search the current catalogue fields, compare listed formats and packs, and submit a qualified request for applicable product information.

14 products available for trade inquiry

Rifadoxy 550 pharmaceutical product packaging

Gastroenterology / Antibiotic

Rifadoxy 550

Rifaximin IP 550 mg

B2B catalogue entry for a tablet listed with rifaximin IP 550 mg, presented for qualified documentation, classification, and trade inquiries.

Rifadoxy 400 pharmaceutical product packaging

Gastroenterology / Antibiotic

Rifadoxy 400

Rifaximin IP 400 mg

B2B catalogue entry for a tablet listed with rifaximin IP 400 mg, presented for qualified documentation, classification, and trade inquiries.

U Raft pharmaceutical product packaging

Gastroenterology / Acidity & GERD

U Raft

Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate

B2B catalogue entry for an oral suspension listed with sodium alginate, sodium bicarbonate, and calcium carbonate. Public pack imagery is withheld pending claim and document review; qualified organizations may request current, applicable information.

Ursofiz 450 pharmaceutical product packaging

Gastroenterology / Hepatobiliary Care

Ursofiz 450

Ursodeoxycholic Acid Sustained Release

B2B catalogue entry for a sustained-release tablet listed with ursodeoxycholic acid; current pack and product details may be requested for qualified review, subject to applicability and availability.

Esomizole-IT pharmaceutical product packaging

Gastroenterology / Acidity & GERD

Esomizole-IT

Esomeprazole (EC) + Itopride (SR)

B2B catalogue entry for a capsule listed with enteric-coated esomeprazole and sustained-release itopride, presented for qualified trade review.

Finozyme Q10 pharmaceutical product packaging

Gastroenterology / Nutritional Support

Finozyme Q10

Coenzyme Q10 + L-Arginine + Omega-3 fatty acid + Selenium + Lycopene

B2B catalogue entry for a softgel capsule listing Coenzyme Q10, L-arginine, omega-3 fatty acid, selenium, and lycopene; current formula details require document review.

Menzovit pharmaceutical product packaging

Gastroenterology / Nutritional Support

Menzovit

Multivitamin, Multimineral, Antioxidants, Iron & Zinc

B2B catalogue entry for a softgel capsule listing vitamins, minerals, antioxidants, iron, and zinc; confirm the current formula from controlled product documents.

Edoflora pharmaceutical product packaging

Gastroenterology / Probiotic

Edoflora

Lyophilized Saccharomyces boulardii 250 mg

B2B catalogue entry for a capsule listed with lyophilized Saccharomyces boulardii 250 mg, presented for product and trade evaluation.

Esomizole-40 pharmaceutical product packaging

Gastroenterology / Acidity & GERD

Esomizole-40

Esomeprazole 40 mg with Sodium Bicarbonate as buffer

B2B catalogue entry for a tablet listed with esomeprazole 40 mg and sodium bicarbonate as a buffer, subject to current document verification.

Ushield pharmaceutical product packaging

Gastroenterology / Ulcer Care

Ushield

Sucralfate + Oxetacaine

B2B catalogue entry for a suspension listed with sucralfate and oxetacaine. Public pack imagery is withheld pending claim and document review; qualified organizations may request current, applicable information.

Ursofiz 300 pharmaceutical product packaging

Gastroenterology / Hepatobiliary Care

Ursofiz 300

Ursodeoxycholic Acid IP 300 mg

B2B catalogue entry for a tablet listed with ursodeoxycholic acid IP 300 mg; qualified buyers may request current pack and product documents, subject to applicability and availability.

Esomizole-D pharmaceutical product packaging

Gastroenterology / Acidity & GERD

Esomizole-D

Esomeprazole (EC) + Domperidone (SR)

B2B catalogue entry for a capsule listed with enteric-coated esomeprazole and sustained-release domperidone, subject to document and market review.

Benzispa Plus pharmaceutical product packaging

Gastroenterology / Antispasmodic

Benzispa Plus

Mebeverine + Chlordiazepoxide

B2B catalogue entry for a tablet listed with mebeverine and chlordiazepoxide, presented for qualified product-document and trade inquiries.

Benzispa SR pharmaceutical product packaging

Gastroenterology / Antispasmodic

Benzispa SR

Mebeverine Hydrochloride Sustained Release

B2B catalogue entry for a sustained-release capsule listed with mebeverine hydrochloride; qualified buyers may request current product and market documents, subject to applicability and availability.

Medoxy Healthcare Pvt Ltd is a B2B pharmaceutical trading company based in Gurgaon, Haryana, India, focused on a gastroenterology product catalogue for distributors, stockists, hospitals, institutions, and other qualified healthcare businesses. The product catalogue lists brand names, compositions, dosage forms, and pack sizes across categories such as proton pump inhibitor combinations, antispasmodics, ursodeoxycholic acid, rifaximin, probiotics, antacid and alginate suspensions, and nutritional supplements.

Catalogue entries include Benzispa SR (Mebeverine Hydrochloride Sustained Release), Benzispa Plus (Mebeverine + Chlordiazepoxide), Esomizole-D (Esomeprazole (EC) + Domperidone (SR)), Ursofiz 300 (Ursodeoxycholic Acid IP 300 mg), Ushield (Sucralfate + Oxetacaine), Esomizole-40 (Esomeprazole 40 mg with Sodium Bicarbonate as buffer), Edoflora (Lyophilized Saccharomyces boulardii 250 mg), Menzovit (Multivitamin, Multimineral, Antioxidants, Iron & Zinc), Finozyme Q10 (Coenzyme Q10 + L-Arginine + Omega-3 fatty acid + Selenium + Lycopene), Esomizole-IT (Esomeprazole (EC) + Itopride (SR)), Ursofiz 450 (Ursodeoxycholic Acid Sustained Release), U Raft (Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate), Rifadoxy 400 (Rifaximin IP 400 mg) and Rifadoxy 550 (Rifaximin IP 550 mg). Names, compositions, images, packaging, and availability may change or differ by market. Verify the exact product and current documents before any regulatory, procurement, or commercial decision.

1. Website content is provided for business and informational purposes only and is not a substitute for professional medical advice, diagnosis, treatment, or approved prescribing information. Patients should consult a qualified healthcare professional.

2. This website does not sell medicines online, display pricing, or accept consumer orders. A listing or inquiry response is not an offer of supply or a guarantee of availability. Terms apply.

3. References to quality, compliance, or external guidelines do not by themselves establish a particular licence, approval, or certification. Evidence applicable to a defined transaction can be requested through the trade inquiry form. See Trade & Quality and Compliance for more information.

Articles on the Healthcare Insights blog follow our content policy. Personal data submitted through inquiry forms is handled as described in the privacy policy.